The duration required for human chorionic gonadotropin (hCG) to mitigate diminished testicular size varies significantly. The timeframe is contingent on several factors, including the degree of initial atrophy, individual responsiveness to hCG, underlying causes contributing to the condition, and the specific dosage and frequency of hCG administration.
Restoring testicular volume can offer benefits such as improved hormone production, potentially leading to enhanced libido, energy levels, and overall well-being. Historically, hCG has been utilized in cases of hypogonadism and infertility, underscoring its role in stimulating testicular function.
